Proving the Business Case for the Internet of Things

IBM helps MedChain build healthcare blockchain

Steve Rogerson
August 21, 2018
 
IBM is partnering Colorado-based early stage company MedChain in building globally compliant healthcare blockchain and decentralised applications (dapps) for electronic medical records (EMRs).
 
The IBM Business Partner Cognition Foundry will help MedChain capitalise on the data protection and performance of IBM LinuxOne, an enterprise Linux server built on mainframe technology. The server, coupled with blockchain is designed to enhance MedChain services that address important challenges in healthcare.
 
Since 2017, MedChain has been giving patients control of their own health information and the ability to delegate access to providers such as doctors and hospitals using a blockchain and distributed storage product for EMR and electronic protected health information (ePHI). The MedChain Network is an extensible, layered architecture and protocol system governed and secured by multiple blockchains that uses a multi-crypto-token framework.
 
This network is built upon the Hyperledger Fabric permissioned blockchain, an open source project hosted by the Linux Foundation and built to run on LinuxOne.
 
MedChain has a common data-layer that allows existing EMR companies to build compliant healthcare dapps, empowering clients with levels of control and insight into their own information.
 
Cognition Foundry is a service provider that enables visionaries to use computing power for the good of society. As it democratises access to enterprise IT, it offers the LinuxOne platform to MedChain developers, creating a blockchain and analytics that can quickly scale to support millions of transactions; similar capabilities have previously only been available to corporations and government agencies.
 
"Incorporating Cognition Foundry's IBM LinuxOne environment into the MedChain architecture, allows a fantastic opportunity to exponentially grow phase II of our network on top of the phase I work of storing and managing EMR," said Steve Wishstar, CTO of MedChain. “Phase II is the data-intensive AI and deep learning involved with analysing all those data. Building on top of the existing MedChain permission structure, only the patient can authorise their data to be used in research. Over the years, this opt-in process will yield petabytes of full lifetimes of contiguous data. The effect of having each patient's data accessible by all care providers means new discoveries can be made based on the holistic view of each and every procedure or medication taken.”
 
Working together, Cognition Foundry and MedChain underpinned by IBM LinuxOne plan to help patients control their data and help researchers discover new treatments and cures.
 
"IBM LinuxOne allows us to quickly set up a complete IT infrastructure capable of supporting millions of transactions for clients like MedChain," said Ron Argent, CEO of Cognition Foundry. "LinuxOne supports pervasive encryption of data and workload isolation, enabling advanced protection against external and internal threats for sensitive data and applications.”